Abnormalities of respiratory control and the respiratory motor unit

Neurologist

Volumn 14, Issue 5, 2008, Pages 273-288

  Nogués, Martín A ^a   Benarroch, Eduardo ^b  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b MAYO CLINIC   (United States)

Author keywords

Apnea; Autonomic network; Control of breathing; Respiratory failure; Respiratory muscle weakness

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ABDOMINAL WALL MUSCULATURE; ACUTE RESPIRATORY FAILURE; AMYOTROPHIC LATERAL SCLEROSIS; ARNOLD CHIARI MALFORMATION; ARTIFICIAL VENTILATION; BETHLEM MYOPATHY; BOTULISM; BRAIN STEM; BREATHING MUSCLE; BREATHING PATTERN; CARBON DIOXIDE TENSION; CHEMORECEPTOR; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DEPRESSION; DIAPHRAGM PARALYSIS; DYSAUTONOMIA; DYSTROPHINOPATHY; EATON LAMBERT SYNDROME; ENZYME DEFICIENCY; EXERCISE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FOREBRAIN; GENE MUTATION; GLUCAN 1,4 ALPHA GLUCOSIDASE DEFICIENCY; GUILLAIN BARRE SYNDROME; HYPOVENTILATION; INTENSIVE CARE UNIT; INTERCOSTAL NERVE; INTOXICATION; INTUBATION; LIMB GIRDLE MUSCULAR DYSTROPHY; LUNG VENTILATION; MOTONEURON; MOTOR UNIT; MUSCLE DISEASE; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; MYOPATHY; MYOTONIC DYSTROPHY; NERVE CELL; NERVE CELL NETWORK; NERVE FIBER; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION; NONINVASIVE POSITIVE PRESSURE VENTILATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OXYGEN TENSION; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PHRENIC NERVE; PHYSIOLOGY; POLIOMYELITIS; POLYNEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATION CONTROL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; SHY DRAGER SYNDROME; SLEEP APNEA SYNDROME; SPEECH; SPINAL CORD; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SPINAL MUSCULAR ATROPHY; STROKE; SUDDEN INFANT DEATH SYNDROME; SUPINE POSITION; SYRINGOMYELIA; TRACHEOSTOMY; VASOMOTOR REFLEX; VITAL CAPACITY; WEIGHT REDUCTION; WHITE MATTER;

HUMANS; MOTOR NEURONS; RESPIRATION DISORDERS; RESPIRATORY CENTER; RESPIRATORY SYSTEM;

EID: 53549083781     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318173e830     Document Type: Review

References (114)

1. Gray PA, Janczewski WA, Meilen N, et al. Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons. Nat Neurosci. 2001;4:927-930.
2. 2 and acid signaling in chemosensitive neurons. Am J Physiol Cell Physiol. 2004;287:C1493-C1526.
3. Richter DW, Spyer KM. Studying rhythmogenesis of breathing: comparison of in vivo and in vitro models. Trends Neurosci. 2001 ;24:464-472.
4. Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci. 2003;26:239-266.
5. Gilchrist JM. Overview of neuromuscular disorders affecting respiratory function. Semin Respir Crit Care Med. 2002;23:191-200.
6. Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care. 2006;51:1016-1021.
7. Polkey MI, Lyall RA, Moxham J, et al. Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry. 1999;66:5-15.
8. Shahrizaila N, Kinnear WJM, Wills AJ. Respiratory involvement in inherited primary muscle conditions. J Neurol Neurosurg Psychiatry. 2006;77:1108-1115.
9. Wang H, Stornetta RL, Rosin DL, et al. Neurokinin-1 receptor- immunoreactive neurons of the ventral respiratory group in the rat. J Comp Neurol. 2001;2:128-146.
10. Guyenet PG, Stornetta RL, Bayliss DA, et al. Retrotrapezoid nucleus: a litmus test for the identification of central chemoreceptors. Exp Physiol. 2005;90:247-253; discussion 253-247.
11. Richerson GB, Wang W, Hodges MR, et al. Homing in on the specific phenotype(s) of central respiratory chemoreceptors. Exp Physiol. 2005; 90:259-266; discussion 266-259.
12. Gozal D, Hathout GM, Kirlew KAT, et al. Localization of putative neural respiratory regions in the human by functional magnetic resonance imaging. J Appl Physiol. 1994;76:2076-2083.
13. Paterson DS, Thompson EG, Kinney HC. Serotonergic and glutamtergic neurons at the ventral medullary surface of the human infant: observations relevant to central chemosensitivity in early human life. Auton Neurosci. 2006;124:112-124.
14. Horn EM, Waldrop TG. Suprapontine control of respiration. Respir Physiol. 1998;114:201-211.
15. Evans KC, Shea SA, Saykin AJ. Functional MRI localisation of central nervous system regions associated with volitional inspirations in humans. J Physiol. 1999;520:383-392.
16. Coulter DL. Partial seizures with apnoea and bradycardia. Arch Neurol. 1984;41:173-174.
17. Nashef L, Walker F, Allen P, et al. Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry. 1996;60:297-300.
18. Moss IR. Canadian Association of Neuroscience Review: respiratory control and behavior in humans: lessons from imaging and experiments of nature. Can J Neurol Sci. 2005;32:287-297.
19. Devereaux MW, Keane JR, Davis RL. Automatic respiratory failure associated with infarction of the medulla. Report of two cases with pathologic study of one. Arch Neurol. 1973;29:46-52.
20. Bogousslavsky J, Khurana R, Deruaz JP, et al. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol. 1990;28:668-673.
21. Morrell MJ, Heywood P, Moosavi SH, et al. Unilateral focal lesions in the rostrolateral medulla influence chemosensitivity and breathing measured during wakefulness, sleep, and exercise. J Neurol Neurosurg Psychiatry. 1999;67:637-645.
22. Nachtmann A, Siebler M, Rose G, et al. Cheyne-Stokes respiration in ischemic stroke. Neurology. 1995;45:820-821.
23. Guo X, Pantoni L, Simoni M, et al. Midlife respiratory function related to white matter lesions and lacunar infarcts in late life: the Prospective Population Study of Women in Gothenburg, Sweden. Stroke. 2006;37: 1658-1662.
24. Newsom-Davis J. Autonomous breathing: report of a case. Arch Neurol. 1974;40:480-483.
25. Howard RS, Wiles CM, Hirsch NP, et al. Respiratory involvement in multiple sclerosis. Brain. 1992;115:479-494.
26. Buyse B, Demedts M, Meekers J, et al. Respiratory dysfunction in multiple sclerosis: a prospective analysis of 60 patients. Eur Respir J. 1997;10:139-145.
27. Smeltzer SC, Utell MJ, Rudick RA, et al. Pulmonary function and dysfunction in multiple sclerosis. Arch Neurol. 1988;45:1245-1249.
28. Nogués M, Gene R, Benarroch E, et al. Respiratory disturbances during sleep in syringomyelia and syringobulbia. Neurology. 1999;52:1777-1783.
29. Haponik EF, Givens D, Angelo J. Syringobulbia-myelia with obstructive sleep apnea. Neurology. 1983;33:1046-1049.
30. Gozal D, Arens R, Omlin KJ, et al. Peripheral chemoreceptor function in children with myelomeningocele and Arnold-Chiari malformation type 2. Chest. 1995;108:425-431.
31. Orner S, Al-Kawi MZ, Bohlega S, et al. Respiratory arrest: a complication of Arnold-Chiari malformation in adults. Eur Neurol. 1996;36: 36-38.
32. Arcaya J, Cacho J, Del Campo F, et al. Arnold-Chiari malformation associated with sleep apnea and central dysregulation of arterial pressure. Acta Neurol Scand. 1993;88:224-226.
33. Greenough G, Sateia M, Fadul CE. Obstructive sleep apnea syndrome in a patient with medulloblastoma. Neuro Oncol. 1999;1:289-291.
34. Corne S, Webster K, McGinn G, et al. Medullary metastasis causing impairment of respiratory pressure output with intact respiratory rhythm. Am J Respir Crit Care Med. 1999;159:315-320.
35. Bateman DE, Gibson GJ, Hudgson P, et al. Central neurogenic hyperventilation in a conscious patient with a primary cerebral lymphoma. Ann Neurol. 1985;17:402-405.
36. Rajagopalan N, Hoffstein V. Astrocytoma presenting with apnea and sinus arrest. Chest. 1994;106:1301-1303.
37. DiMario FJ Jr. Brainstem tubers presenting as disordered breathing in tuberous sclerosis complex. J Child Neurol. 1995;10:407-409.
38. Gilmore RL, Falace P, Kanga J, et al. Sleep-disordered breathing in Mobius syndrome. J Child Neurol. 1991;6:73-77.
39. Yasaki E, Saito Y, Nakano K, et al. Characteristics of breathing abnormality in Leigh and its overlap syndromes. Neuropediatrics. 2001;32:299-306.
40. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36.
41. Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord. 2007;22:155-161.
42. Chokroverty S, Sharp JT, Barron KD. Periodic respiration in erect posture in Shy-Drager syndrome. J Neurol Neurosurg Psychiatry. 1978;41:980-986.
43. Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm. 2005;20(suppl 12):557-563.
44. Glass GA, Josephs KA, Ahlskog JE. Respiratory insufficiency as the primary presenting symptom of multiple-system atrophy. Arch Neurol. 2006;63:978-981.
45. Munschauer FE, Loh L, Bannister R, et al. Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology. 1990;40:677-679.
46. Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord. 2000;15:699-704.
47. Vetrugno R, Provini F, Cortelli P, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med. 2004;5:21-30.
48. Bannister R, Gibson W, Michaels L, et al. Laryngeal abductor paralysis in multiple system atrophy. A report on three necropsied cases, with observations on the laryngeal muscles and the nucleus ambiguus. Brain. 1981;104:351-368.
49. Isozaki E, Shimizu T, Takamoto K, et al. Vocal cord abductor paralysis (VCAP) in Parkinson's disease: difference from VCAP in multiple system atrophy. J Neurol Sci. 1995; 130:197-202.
50. Sadaoka T, Kakitsuba N, Fujiwara Y, et al. Sleep-related breathing disorders in patients with multiple system atrophy and vocal cord palsy. Sleep. 1996;19:479-484.
51. Isono S, Shiba K, Yamaguchi M, et al. Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol. 2001; 536:237-249.
52. Merlo IM, Occhini A, Pacchetti C, et al. Not paralysis, but dystonia causes stridor in multiple system atrophy. Neurology. 2002;58:649-652.
53. Cormican LJ, Higgins S, Davidson AC, et al. Multiple system atrophy presenting as central sleep apnoea. Eur Respir J. 2004;24:323-325.
54. Tsuda T, Onodera H, Okabe S, et al. Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Ann Neurol. 2002;52: 367-371.
55. McNicholas WT, Rutherford R, Grossman R, et al. Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis. 1983;128:429-433.
56. Benarroch EE, Schmeichel AM, Low PA, et al. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy. Brain. 2007;130:469-475.
57. Hovestadt A, Bogaard JM, Meerwaldt JD, et al. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1989;52:329-333.
58. Hardie RJ, Efthimiou J, Stern GM. Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1986;49:1326.
59. Perry TL, Bratty PJ, Hansen S, et al. Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol. 1975;32:108-113.
60. Purdy A, Hahn A, Barnett HJ, et al. Familiar fatal Parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol. 1979;6: 523-531.
61. Roy EP III, Riggs JE, Martin JD, et al. Familial parkinsonism, apathy, weight loss, and central hypoventilations: successful long-term management. Neurology. 1988;38:637-639.
62. Tsuboi Y, Dickson DW, Nabeshima K, et al. Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol. 2008;115:263-268.
63. Kinney HC, Myers MM, Belliveau RA, et al. Subtle autonomic and respiratory dysfunction in sudden infant death syndrome associated with serotonergic brainstem abnormalities: a case report. J Neuropathol Exp Neurol. 2005;64:689-694.
64. Gaultier C, Amiel J, Dauger S, et al. Genetics and early disturbances of breathing control. Pediatr Res. 2004;55:729-733.
65. Axelrod FB, Abularrage JJ. Familial dysautonomia. A prospective study of survival. J Pediatr. 1982;101:234-236.
66. Stemper B, Hilz MJ, Bernardi L, et al. Hypoxic chemoreceptor Stimulation induces paradoxic cardiovascular responses in familial dysau-tonomia. Clin Auton Res. 2001;11:187.
67. Kidd D, Williams AJ, Howard RS. Poliomyelitis. Postgrad Med J. 1996;72:641-647.
68. Dalakas M, Illa I. Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology. Adv Neurol. 1991;56:495-511.
69. Dean AC, Graham BA, Dalakas M, et al. Sleep apnea in patients with postpolio syndrome. Ann Neurol. 1998;43:661-664.
70. Blomstrand A, Bake B. Post-polio lung function. Scand J Rehabil Med. 1992;24:43-49.
71. Steljes DG, Kryger MH, Kirk BW, et al. Sleep in postpolio syndrome. Chest. 1990;98:133-144.
72. Bach JR, Alba AS. Pulmonary dysfunction and sleep disordered breathing as post-polio sequelae: evaluation and management. Orthopedics. 1991;14:1329-1337.
73. Mitsumoto H, Chad DA, Pioro EP. Course and prognosis. In: Mit-sumoto H, Chad DA, Pioro EP, eds. Amyotrophic Lateral Sclerosis. Philadelphia, PA: FA Davis Company; 1998:151-163.
74. Lechtzin N, Lange DJ, Davey C, et al. Measures of dyspnea in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2007;35:98-102.
75. Samaha FJ, Buncher CR, Russman BS, et al. Pulmonary function in spinal muscular atrophy. J Child Neurol. 1994;9:326-329.
76. Hughes RA, Bihari D. Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry. 1993;56:334-343.
77. Mier-Jedrzejowicz AK, Brophy C, Green M. Respiratory muscle function in myasthenia gravis. Am Rev Respir Dis. 1988;138:867-873.
78. Quera-Salva MA, Guillerminault C, Chevret S, et al. Breathing disorders during sleep in myasthenia gravis. Ann Neurol. 1992;31:86-92.
79. Laroche CM, Mier AK, Spiro SG, et al. Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome. Thorax. 1989;44:913-918.
80. Nicolle MW, Stewart DJ, Remtulla H, et al. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve. 1996;19:1328-1333.
81. Tim RW, Sanders DB. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1994; 17:995-1001.
82. Sandrock CE, Murin S. Clinical predictors of respiratory failure and ling-term outcome in black tar heroin-associated wound botulism. Chest. 2001;120:562-566.
83. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care. 2001;5:211-215.
84. Besser R, Gutmann L, Dillmann U, et al. End-plate dysfunction in acute organophosphate intoxication. Neurology. 1989;39:561-567.
85. Pellegrini M, Laforet P, Orlikowski D, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Resp J. 2005;26:1024-1031.
86. Margolis ML, Hill AR. Acid maltase deficiency in an adult: evidence for improvement in respiratory function with high-protein dietary therapy. Am Rev Respir Dis. 1986;134:328-331.
87. Mellies U, Ragette R, Schwake C, et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology. 2001;57: 1290-1295.
88. Rosenow EC, Engel AG. Acid maltase deficiency in adults presenting as respiratory failure. Am J Med. 1978;64:485-491.
89. Trend PS, Wiles CM, Spencer GT, et al. Acid maltase deficiency in adults. Diagnosis and management in five cases. Brain. 1985; 108:845-860.
90. Mellies U, Stehling F, Dohna-Schwake C, et al. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology. 2005;64:1465-1467.
91. DiMauro S, Hartlage PL. Fatal infantile form of muscle Phosphorylase deficiency. Neurology. 1978;28:1124-1129.
92. Kurz D, Aguzzi A, Scherer TA. Decompensated cor pulmonale as the first manifestation of adult-onset myopathy. Respiration. 1998;65:317-319.
93. Bruno C, Sacco O, Santorelli FM, et al. Mitochondrial myopathy and respiratory failure associated with a new mutation in the mitochondrial transfer ribonucleic acid glutamic acid gene. J Child Neurol. 2003:18: 300-303.
94. Yang CC, Hwang CC, Pang CY, et al. Mitochondrial myopathy with predominant respiratory dysfunction in a patient with A3243G mutation in the mitochondrial tRNA(Leu(UUR))gene. J Formos Med Assoc. 1998;97:715-719.
95. Baydur A, Gilgoff 1, Prentice W, et al. Decline in respiratory function and experience with long-term assisted ventilation in advanced Duchenne's muscular dystrophy. Chest. 1990;97:884-889.
96. Politano L, Nigro V, Passamano L, et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord. 2001;11:178-185.
97. Fardeau M, Eymard B, Mignard C, et al. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord. 1996;6: 447-453.
98. Dirik E, Aydin A, Kurul S, et al. Limb girdle muscular dystrophy type 2A presenting with cardiac arrest. Pediatr Neurol. 2001;24:235-237.
99. Poppe M, Cree L, Bourke J, et al. The phenotype of limb-girdle muscular dystrophy type 21. Neurology. 2003;60:1246-1251.
100. Haq RU, Speer MC, Chu ML, et al. Respiratory muscle involvement in Bethlem myopathy. Neurology. 1999;52:174-176.
101. Wohlgemuth M, van der Kooi EL, van Kesteren RG, et al. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology. 2004; 63:176-178.
102. Dedrick DL, Brown LK. Obstructive sleep apnea syndrome complicating oculopharyngeal muscular dystrophy. Chest. 2004;125:334-336.
103. Christopher K, Horkan C, Patterson RB, et al. Oculopharyngeal muscular dystrophy complicating airway management. Chest. 2001; 120: 2101-2103.
104. Rowe PW, Eagle M, Pollitt C, et al. Multicore myopathy: respiratory failure and paraspinal muscle contractures are important complications. Dev Med Child Neurol. 2000;42:340-343.
105. Ververs CC, Van der Meche FG, Verbraak AF, et al. Breathing pattern awake and asleep in myotonic dystrophy. Respiration. 1996;63:1-7.
106. Ono S, Takahashi K, Jinnai K, et al. Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology. 1998;51:1121-1124.
107. Yamaguchi M, Arai K, Asahina M, et al. Laryngeal stridor in multiple system atrophy. Eur Neurol. 2003;49:154-159.q
108. Nonaka M, Imai T, Shintani T, et al. Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci. 2006;247:53-58.
109. Lechtzin N. Respiratory effects of amyotrophic lateral sclerosis: problems and solutions. Respir Care. 2006;51:871-881.
110. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002; 12:926-929.
111. Orlikowski D, Prigent H, Sharshar T, et al. Respiratory dysfunction in Guillain-Barre syndrome. Neurocrit Care. 2004;1:415-422.
112. Marinelli WA, Leatherman JW. Neuromuscular disorders in the intensive care unit. Crit Care Clin. 2002;18:915-929.
113. Thomas CE, Mayer SA, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48:1253-1260.
114. Rabinstein A, Wijdicks EF. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology. 2002;59:1647-1649.